Access cutting-edge hypothalamic obesity treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access hypothalamic obesity specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypothalamic obesity treatment provided free
This is a sub-study of Study RM-493-040 (NCT05774756). The goal of this sub-study is to learn how well Setmelanotide works to improve weight reduction, hunger, and quality of life in patients 4 years of age and older with congenital Hypothalamic Obesity (cHO). To determine how well setmelanotide works and how safe it is, patients with cHO will take a daily injection of either setmelanotide or placebo and complete trial assessments for up to 26 weeks on a therapeutic regimen.
Sponsor: Rhythm Pharmaceuticals, Inc.
Check if you qualify for this hypothalamic obesity clinical trial in Chicago, IL
If you're searching for hypothalamic obesity treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypothalamic obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.